Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by NewToInvesting7on Jun 25, 2021 10:53am
177 Views
Post# 33450208

RE:THIS IS UGLY

RE:THIS IS UGLY
frewil11 wrote: What I started with 300,000 shares divided by 8 = 37,500 divided by 2 = 18,750  shares left , what a complete disaster.


**Using your scenario, and assuming you paid $0.10 per share pre 8-1 split**

I don't care that the share count went from 300,000 to 37,500 currently, and possible to 18,750 in the future.

What I do care about is the SP vale of each post consolidated share.  If the SP remains in line with consolidation, then all is well.  So in this case, if the SP was now ~$0.80 (or ~$1.60 if the 2-1 split is executed), then why worry?  

How StageZero pivots from here, whether they can release material NRs and show a significant increase in revenues plus growth in positive EBITDA in Q3/Q4 will determine whether the 8-1 consolidation and more importantly, Aristotle, was worth the market reaction over the past 3 months.

I am still holding because I see the positives, but I do understand the panic and uneasiness that exists.  
 

Cheers!


<< Previous
Bullboard Posts
Next >>